Literature DB >> 6197988

8;21 translocation in acute granulocytic leukaemia: cytological, cytochemical and clinical features.

D M Swirsky, Y S Li, J G Matthews, R J Flemans, J K Rees, F G Hayhoe.   

Abstract

Thirty patients with the 8;21 translocation and three with closely related variants have been studied. Ages ranged from 3 to 64 years (mean 28.3). Thirty-one were entered into the MRC's 8th Acute Myeloid Leukaemia Trial. Twenty-nine (88%) achieved complete remission. Marrow smears from most patients showed granulocytic maturation (M2, FAB classification) with characteristic abnormalities, but at least six showed predominantly myeloblastic (M1) morphology. The blast cells were markedly heterogeneous with regard to size and nuclear cytoplasmic ratio. Typical staining patterns were observed in the blast cells using Sudan black B and diaminobenzidine peroxidase stains, and to a lesser extent with periodic acid-Schiff and chloroacetate esterase. Butyrate esterase was negative in all cases. Auer rods were present in the granulocyte precursors in 31 cases and in eosinophil precursors in two cases. In most cases the existence of the translocation was predicted from the cytological and cytochemical findings. Seven patients developed solid leukaemic deposits, principally in the mastoid cavities, orbital cavities or thoracic spine (extradural).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6197988     DOI: 10.1111/j.1365-2141.1984.tb03948.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  26 in total

1.  Acute myeloid leukemia (AML-M2) with translocation (8;21) (q22;q22) and abnormal eosinophilic precursors in the bone marrow--a case report.

Authors:  Oneal Gupta; Roopak Aggarwal; Rajni Prasad
Journal:  Indian J Pediatr       Date:  2011-06-01       Impact factor: 1.967

2.  Isolation of a yeast artificial chromosome spanning the 8;21 translocation breakpoint t(8;21)(q22;q22.3) in acute myelogenous leukemia.

Authors:  J Gao; P Erickson; K Gardiner; M M Le Beau; M O Diaz; D Patterson; J D Rowley; H A Drabkin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

Review 3.  Chromosome abnormalities in acute leukemia: its clinical implications and age of onset.

Authors:  R Abe; Y Shiga; T Uchida; S Kariyone
Journal:  Indian J Pediatr       Date:  1989 Nov-Dec       Impact factor: 1.967

4.  Isolated biliary granulocytic sarcoma followed by acute myelogeneous leukemia with multilineage dysplasia: a case report and literature review.

Authors:  Chang Ohk Sung; Young Hyeh Ko; Cheol Keun Park; Kee Taek Jang; Jin Seok Heo
Journal:  J Korean Med Sci       Date:  2006-06       Impact factor: 2.153

5.  Clinical and prognostic investigations on M2/t(8;21) acute nonlymphocytic leukemia.

Authors:  F J Cheng; A D Yang; H B Fei; H Tian
Journal:  J Tongji Med Univ       Date:  1993

6.  Granulocytic sarcoma in MLL-positive infant acute myelogenous leukemia: fluorescence in situ hybridization study of childhood acute myelogenous leukemia for detecting MLL rearrangement.

Authors:  K U Park; D S Lee; H S Lee; C J Kim; H I Cho
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

7.  Recurrence of acute myelogenous leukemia with the same AML1/ETO breakpoint as at diagnosis after complete remission lasting 15 years: analysis of stored bone marrow smears.

Authors:  Norifumi Tsukamoto; Masamitsu Karasawa; Yoko Tanaka; Akihiko Yokohama; Hideki Uchiumi; Takafumi Matsushima; Hirokazu Murakami; Yoshihisa Nojima
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

8.  Hematopoietic stem cell expansion and distinct myeloid developmental abnormalities in a murine model of the AML1-ETO translocation.

Authors:  Cristina G de Guzman; Alan J Warren; Zheng Zhang; Larry Gartland; Paul Erickson; Harry Drabkin; Scott W Hiebert; Christopher A Klug
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

9.  Therapeutic modalities for central nervous system involvement by granulocytic sarcoma (chloroma) in children with acute nonlymphocytic leukemia.

Authors:  Y Takaue; S J Culbert; T Baram; A Cork; J M Trujillo
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

10.  Monitoring AML1-ETO and CBFbeta-MYH11 transcripts in acute myeloid leukemia.

Authors:  John A Liu Yin; Lindsay Frost
Journal:  Curr Oncol Rep       Date:  2003-09       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.